Roche Holding AG
Roche
Pricing is indicative. Past performance is not a reliable indicator of future results. Client sentiment is provided for general information only, is historical in nature and is not intended to provide any form of trading or investment advice - it must not form the basis of your trading or investment decisions.
Trading Conditions
ATP Margin
0.04
Contract Size Currency per 1 Lot Symbol
1 Share
Min/Max Trade Size (lots)
1 Share / 25000
Schedule and Fees
Market Open
Monday 09:00 CET
Market Closed
Friday 17:30 CET
Trading Break
17:30 - 09:00 CET
3 Day Financing
Wednesday
Long & Short Position Overnight Fee
displayed on the trading platform
FAQ
Roche, a Swiss multinational corporation specializing in pharmaceuticals and diagnostics, occupies a prominent role in the worldwide healthcare sector. Boasting a legacy of more than a century, the company stands at the forefront of creating solutions for a diverse array of medical issues.
The company's operations are divided into two main divisions: pharmaceuticals and diagnostics. In the Pharmaceuticals division, Roche focuses on the research, development, and commercialisation of a diverse portfolio of prescription drugs, with an emphasis on oncology, immunology, infectious diseases, neuroscience, and rare diseases. In the Diagnostics division, Roche develops advanced diagnostic tools that enable healthcare professionals to accurately diagnose and monitor medical conditions.
Roche is listed on the SIX Swiss Exchange, the principal stock exchange in Switzerland, with the ticker symbol “ROG”. It is one of the largest companies on the Swiss Market Index (SMI), which is the most important stock index in Switzerland and includes the top 20 companies by market capitalization listed on the SIX.
